logobeta
본 영문본은 리걸엔진의 AI 번역 엔진으로 번역되었습니다. 수정이 필요한 부분이 있는 경우 피드백 부탁드립니다.
텍스트 조절
arrow
arrow
(영문) 서울중앙지방법원 2020.05.22 2019가단59388
보험금 청구의 소
Text

1. The plaintiff's claim is dismissed.

2. The costs of lawsuit shall be borne by the Plaintiff.

Reasons

1. Basic facts;

A. On April 4, 2016, the Plaintiff entered into a “C” contract with the Defendant, and the grounds for and amount of the payment are as follows:

(Terms and Conditions shall be as shown in Attached Form 1). Payments subject to payment (won)

1. Main contract;

(a) When the insured has been diagnosed and confirmed as cancer after the date of commencing cancer security (limited to the first time, in cases of a pregrance cancer, limited to the case of the insured in cases of the insured in cases of a female, and limited to the case of the insured in cases of the insured in cases of the first time): 10,000,000 mar cancer other than the highum cancer, 10,000 mar cancer, 200,000 mar cancer;

B. On September 13, 2016, the Plaintiff entered into a “D” contract with the Defendant, and the grounds for and amount of the payment are as follows:

(Terms and Conditions shall be as shown in Attached Form 2). Payments subject to payment (won)

1. Main contract;

(a) When the insured of living expenses during the cover period after cancer diagnosis becomes final and conclusive after five years from the date the first diagnosis becomes final and conclusive at the time of the first diagnosis as "specific cancer" during the cover period of the cancer guarantee (the highest 60 times);

3. A special-purpose agreement for high or specific cancer diagnosis (a renewed 15-year period);

(a) When the insured has been diagnosed and confirmed as "specific cancer" after the date of commencement of cancer security (limited to the first time) during the period of a special contract for a specific cancer examination benefit: 50,000,00 [at least one year] per month [at least one year] 20,000,00 [based on 10,000,00 ] 10,000 ], and 1, Eul evidence 1, 2, and 2 of the Act;

2. The parties' assertion

A. On August 23, 2019, the Plaintiff alleged that he/she had been diagnosed as leuk-type cancer (blood cancer) and wing-type cancer (blood type) as a result of the surgery conducted at the F Hospital located in Yeongdeungpo-gu Seoul Metropolitan Government E.

Therefore, the defendant 1-A.

The contract under subsection 40 million won, 20 million won, and 1-b.

The amount of living expenses between KRW 20 million and KRW 10 million and KRW 60,000.

arrow